No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019

Reata phase two data on GFR increase is based on historical controls and here I was quibbling with you about the marginal p value for our data against placebo :)

The more I research  RVX it is hard not to get excited about the upcoming results. If successfull, as I now believe they will be, this will be the start of a new paradigm in medicine.

Share
New Message
Please login to post a reply